#molecule

- Asia Pacific must rapidly identify and adopt the next generation of low-carbon and scalable infrastructure to ...

 AbbVie (NYSE: ABBV) strengthened its manufacturing capabilities by breaking ground Thursday on a new US$223 ...

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces dosing of the first patient in Phase III clinical trial ...

Indonesia, on account of its strategic location, has been enabling astronomers to make observations of celestial ...

Allorion Therapeutics ("Allorion"), a US and China-based biotechnology company that focuses on the discovery of ...

The urgency to increase liquefied natural gas (LNG) production and improve the security of supply will be central ...

HighTide Therapeutics Inc. ("HighTide"), a globally integrated clinical-stage biopharmaceutical company developing ...

The National Research and Innovation Agency (BRIN) will seek to further biodiversity research on a molecular level by ...

LintonPharm Co., Ltd., a China-based biopharmaceutical company focusing on the development of T cell engaging ...

EIG, a leading institutional investor to the global energy and infrastructure sectors, and Fluxys, a leading energy ...

LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell ...

Global manufacturer Milliken & Company today released its third annual corporate sustainability report, entitled ...

LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell ...

Milliken & Company is pleased to announce Cindy Boiter has been promoted to executive vice president and president ...

Regulatory News:     Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum ...